Infectious Complications in Pediatric Renal Transplant Recipients Who Received Alemtuzumab or Rabbit Anti-Thymocyte Globulin Induction

被引:0
|
作者
Doares, W. [1 ]
Chen, A. [1 ]
Lin, J. -J. [1 ]
Hart, L. [1 ]
Spainhour, L. [1 ]
Kaczmorski, S. [1 ]
Rogers, J. [1 ]
Stratta, R. [1 ]
Farney, A. [1 ]
机构
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1407
引用
收藏
页码:440 / 441
页数:2
相关论文
共 50 条
  • [41] Alemtuzumab versus anti-thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen
    Rikard, Rachel A.
    Chargualaf, Laura M.
    Coulter, Carolyn
    Weimer, Eric T.
    Schmitz, John L.
    Kotzen, Elizabeth S.
    Prom, Alyson
    Toledo, Alexander H.
    Szempruch, Kristen R.
    CLINICAL TRANSPLANTATION, 2024, 38 (02)
  • [42] Causal Relationship between Anti-Thymocyte Globulin Induction Therapy and Development of Monomorphic PTLD in Renal Transplant Recipients
    Soliman, K.
    Ali, H.
    Fulop, T.
    Osman, A.
    Halawa, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 837 - 837
  • [43] A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation
    Farney, Alan
    Sundberg, Aimee
    Moore, Phillip
    Hartmann, Erica
    Rogers, Jeff
    Doares, William
    Jarrett, Anne
    Adams, Patricia
    Stratta, Robert
    CLINICAL TRANSPLANTATION, 2008, 22 (01) : 41 - 49
  • [44] Anti-Thymocyte Globulin vs. Alemtuzumab: A Comparison of Long-Term Outcomes among Renal Transplant Recipients.
    Loncharic, E.
    Dodson, A.
    Gutierrez, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 678 - 678
  • [45] Retrospective Evaluation of Rabbit Anti-Thymocyte Globulin (rATG) Induction in Heart Transplant Patients
    Lee, G.
    Cheng, R.
    Wu, C.
    Vasbinder, A.
    Wong, B.
    Farris, S.
    Fishbein, D.
    Wong, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S133 - S133
  • [46] Timing of Rabbit Anti-Thymocyte Globulin Induction Therapy: Is There an Impact on Kidney Transplant Outcomes?
    Harrison, J.
    Hamandi, B.
    Li, Y.
    Famure, O.
    Kim, S. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 254 - 254
  • [47] Administration of equine anti-thymocyte globulin via peripheral vein in renal transplant recipients
    Rahman, GF
    Hardy, MA
    Cohen, DJ
    TRANSPLANTATION, 2000, 69 (09) : 1958 - 1960
  • [48] EFFECTS OF ANTI-THYMOCYTE GLOBULIN ON CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS
    RUBIN, RH
    COSIMI, AB
    HIRSCH, MS
    HERRIN, JT
    RUSSELL, PS
    TOLKOFFRUBIN, NE
    TRANSPLANTATION, 1981, 31 (02) : 143 - 145
  • [49] Evaluation of Dose Dependent Rabbit Anti-Thymocyte Globulin Induction in Risk-Stratified Kidney Transplant Recipients.
    Gutman, I.
    Misel, M.
    Mckay, D.
    Hemming, A.
    Kerr, J.
    Mekeel, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 613
  • [50] A prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in mdney and pancreas transplantation
    Farney, A. C.
    Singh, R.
    Rogers, J.
    Ashcroft, E.
    Hartmann, E.
    Hart, L.
    Doares, W.
    Gautreaux, M.
    Iskandar, S.
    Adams, P.
    Stratta, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 320 - 320